Sana Alajmovic has assumed the role as CEO of Enzymatica

Sana Alajmovic has now officially started her role as Chief Executive Officer of the company.

Enzymatica stands on a strong scientific foundation, with a unique barrier technology and growing international interest in ColdZyme. As the company enters its next phase, Sana brings extensive experience in leadership, strategy and commercial development.

“I’m truly excited to join Enzymatica at this important stage. The combination of strong science, a unique technology platform and a highly committed team creates a fantastic foundation for long-term growth. I very much look forward to building the next chapter together,” says Sana Alajmovic.